MD Anderson Moon Shoot Program, page-110

Just read through here is everyone’s best advice I am sure .

There is huge education , and yes , valuation models
@wombat777 is resident analyst in this respect. Follow his posts and others .

**Read about the current 5-Path pathway for Bisantrene- the basic plan .

Watch the 2019 AGM presentation to investors - end of Nov. 2019 .

Listen to and read last weeks investor presentation- with Prof Borj Andersson , Dr John Cullity ( chairman) and Dr Daniel Tillet (CEO) presenting, and answering questions regarding the latest Israel trial results and Race oncology work and where to expect from here- with how the multiple trials planned to progress Bisantrene towards approvals , and overall progress with Bisantrene will infold for the next months and year.

Much is repeated regularly in here .

You’ve been to the Website ?
Check out wombats posts for company true valuations - even in recent days wombat has posted , outlining real examples and validation of Values for RAC.
( hint - and we believe, this is only the beginning . Good to finally have confirmation of Bisantrene compelling efficacy - independently and from trial at Sheba , Israel. )